Literature DB >> 15870826

Disruption of Netrin G1 by a balanced chromosome translocation in a girl with Rett syndrome.

Isabella Borg1, Kristine Freude, Sabine Kübart, Kirsten Hoffmann, Corinna Menzel, Franco Laccone, Helen Firth, Malcolm A Ferguson-Smith, Niels Tommerup, Hans-Hilger Ropers, David Sargan, Vera M Kalscheuer.   

Abstract

We have identified a girl with characteristic features of Rett syndrome (RTT) who carries a de novo balanced translocation involving chromosomes 1 and 7. Both breakpoints were mapped by fluorescence in situ hybridization with selected genomic clones from the regions of interest. Southern blot hybridisations, utilizing probes derived from breakpoint spanning BACs, detected several aberrant fragments specific for the patient. Sequence analysis of the cloned junction fragment indicated that on chromosome 1 the predominantly brain-expressed Netrin G1 (NTNG1) gene is disrupted, whereas on chromosome 7 there was no indication for a truncated gene. The chromosome 1 breakpoint lies within the 3' part of NTNG1 and affects alternatively spliced transcripts, suggesting that the phenotype in this patient is the result of disturbed NTNG1 expression. In silico translation of the NTNG1 splice variants predicted protein isoforms with different C-termini: one membrane bound through a glycosylphosphatidylinositol anchor and the other soluble. The membrane-bound protein isoform would be affected by the breakpoint, whereas the soluble form would remain intact. Our results suggest that the central nervous system is sensitive to NTNG1 expression levels and that NTNG1 is a novel candidate disease gene for RTT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870826     DOI: 10.1038/sj.ejhg.5201429

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  35 in total

1.  tSNP-based identification of allelic loss of gene expression in a patient with a balanced chromosomal rearrangement.

Authors:  Gregory F Guzauskas; Kennedy Ukadike; Lynn Rimsky; Anand K Srivastava
Journal:  Genomics       Date:  2007-01-22       Impact factor: 5.736

Review 2.  Balanced translocations in mental retardation.

Authors:  Geert Vandeweyer; R Frank Kooy
Journal:  Hum Genet       Date:  2009-04-05       Impact factor: 4.132

3.  Breakpoint mapping and array CGH in translocations: comparison of a phenotypically normal and an abnormal cohort.

Authors:  Julia Baptista; Catherine Mercer; Elena Prigmore; Susan M Gribble; Nigel P Carter; Viv Maloney; N Simon Thomas; Patricia A Jacobs; John A Crolla
Journal:  Am J Hum Genet       Date:  2008-03-27       Impact factor: 11.025

4.  Identification of a novel CDKL5 exon and pathogenic mutations in patients with severe mental retardation, early-onset seizures and Rett-like features.

Authors:  Nils Rademacher; Melanie Hambrock; Ute Fischer; Bettina Moser; Berten Ceulemans; Wolfgang Lieb; Rainer Boor; Irina Stefanova; Gabriele Gillessen-Kaesbach; Charlotte Runge; Georg Christoph Korenke; Stefanie Spranger; Franco Laccone; Andreas Tzschach; Vera M Kalscheuer
Journal:  Neurogenetics       Date:  2011-02-12       Impact factor: 2.660

5.  Nonobese diabetic congenic strain analysis of autoimmune diabetes reveals genetic complexity of the Idd18 locus and identifies Vav3 as a candidate gene.

Authors:  Heather I Fraser; Calliope A Dendrou; Barry Healy; Daniel B Rainbow; Sarah Howlett; Luc J Smink; Simon Gregory; Charles A Steward; John A Todd; Laurence B Peterson; Linda S Wicker
Journal:  J Immunol       Date:  2010-04-02       Impact factor: 5.422

6.  NTNG1 mutations are a rare cause of Rett syndrome.

Authors:  Hayley L Archer; Julie C Evans; David S Millar; Peter W Thompson; Alison M Kerr; Helen Leonard; John Christodoulou; David Ravine; Lazarus Lazarou; Lucy Grove; Christopher Verity; Sharon D Whatley; Daniela T Pilz; Julian R Sampson; Angus J Clarke
Journal:  Am J Med Genet A       Date:  2006-04-01       Impact factor: 2.802

7.  Homozygous frameshift variant in NTNG2, encoding a synaptic cell adhesion molecule, in individuals with developmental delay, hypotonia, and autistic features.

Authors:  Bassam Abu-Libdeh; Motee Ashhab; Maher Shahrour; Muhannad Daana; Anwar Dudin; Orly Elpeleg; Simon Edvardson; Tamar Harel
Journal:  Neurogenetics       Date:  2019-08-02       Impact factor: 2.660

8.  Analysis of severely affected patients with dihydropyrimidine dehydrogenase deficiency reveals large intragenic rearrangements of DPYD and a de novo interstitial deletion del(1)(p13.3p21.3).

Authors:  André B P van Kuilenburg; Judith Meijer; Adri N P M Mul; Raoul C M Hennekam; Jan M N Hoovers; Christine E M de Die-Smulders; Peter Weber; Andrea Capone Mori; Jörgen Bierau; Brian Fowler; Klaus Macke; Jörn Oliver Sass; Rutger Meinsma; Julia B Hennermann; Peter Miny; Lida Zoetekouw; Raymon Vijzelaar; Joost Nicolai; Bauke Ylstra; M Estela Rubio-Gozalbo
Journal:  Hum Genet       Date:  2009-03-19       Impact factor: 4.132

Review 9.  De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention.

Authors:  Julie Gauthier; Guy A Rouleau
Journal:  Genome Med       Date:  2012-09-25       Impact factor: 11.117

Review 10.  The netrin protein family.

Authors:  Sathyanath Rajasekharan; Timothy E Kennedy
Journal:  Genome Biol       Date:  2009-09-29       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.